Not available
Quote | Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Last: | $437.49 |
---|---|
Change Percent: | -0.55% |
Open: | $430.93 |
Close: | $437.49 |
High: | $439.26 |
Low: | $428.62 |
Volume: | 1,059,042 |
Last Trade Date Time: | 05/15/2024 03:00:00 am |
News | Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director. Dr. Schneider has more than two decades of experience in the health care industry as a physician, scientist and health c...
2024-05-15 06:47:21 ET Summary Tweedy Browne's 13F portfolio value increased to $2.13B, with 45 holdings. Berkshire Hathaway remains the largest position, followed by Alphabet, Johnson & Johnson, FMC Corporation, and Ionis Pharma. New stakes include Envista Holdings, while...
Message Board Posts | Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $VRTX News Article - This Is My Highest-Conviction Stock to Own in 2023 and Beyond | whytestocks | investorshangout | 03/23/2023 7:05:46 PM |
whytestocks: $VRTX News Article - 2 No-Brainer Biotech Stocks to Buy Right Now | whytestocks | investorshangout | 12/22/2022 8:20:45 PM |
whytestocks: $VRTX News Article - Vertex to Participate in Upcoming Investor Conferences | whytestocks | investorshangout | 11/09/2022 6:55:51 PM |
whytestocks: $VRTX News Article - Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory | whytestocks | investorshangout | 09/27/2022 4:06:04 PM |
FDA approval for Cystic Fibrosis drug for children. Why | Glider549 | investorshub | 09/06/2022 1:26:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Vertex Pharmaceuticals Incorporated Company Name:
VRTX Stock Symbol:
NASDAQ Market:
On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management said under $30, Pfizer Inc. (NYSE:PFE) is a g...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director. Dr. Schneider has more than two decades of experience in the health care industry as a physician, scientist and health c...
2024-05-15 01:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...